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ABSTRACT : The Carcinoembryonic antigen (CEA) levels in portal blood in 87 
colorectal patients were studied in correlation with the immunoreactivity of tumor 
CEA stained by immunoperoxidase method in order to examine how serum CEA 
increases. Portal blood CEA increased by operative maneuver. Portal blood CEA 
was correlated with the Duke's staging, and revealed higher positive rates than CEA 
in peripheral blood in each stage. The amount of CEA in well differentiated and 
moderately differentiated adenocarcinoma was higher than that of poorly different-
iated adenocarcinoma. However, moderately differentiated adenocarcinoma reveal-
ed the highest level of portal blood CEA (p<0.05). Significant increase of portal CEA 
was observed when CEA was found in cytoplasm and stroma immunohistochemical-
ly besides in strongly positive stain, and when cancer was proved pathologically to 
invade over the intestinal wall. This study suggests that how CEA is transported 
from the tumor to the portal vein which is the most important decisive factor of the 
CEA level in peripheral blood.
       INTRODUCTION 
 The carcinoembryonic antigen (CEA) of col-
orectal cancer is the most valuable tumor mar-
ker and its assay is now widely used. However, 
about half of the patients with colorectal can-
cer do not indicate elevated CEA levels in periph-
eral blood. Consequently it is necessary to find 
out how CEA is tansferred from cancer tissue 
producing CEA into circulating blood, as the 
level of CEA in peripheral blood does not fully 
reflect the cancer tissue. Most researches about 
the mechanism of raised blood CEA levels have 
been concerned with the assessment of raised 
CEA in peripheral blood, using the histopatho-
logical findings of the tumor, the staining and 
the localization of CEA by immunohistochemi-
cal method, 1-5) and the measurement of CEA 
in extracts of tumor, 6-8 ) but a few has studied 
protal CEA.8) In the present study, we measur-
ed portal CEA levels from the blood of the 
drainage vein which was drawn during the sur-
gical operations of the patients with colorectal 
cancer, and studied the relationship between 
portal CEA and CEA in tumor by inununohisto-
chemical staining. 
   MATERIALS AND METHODS 
Patients 
 Eighty-seven patients who underwent resec-
tion for primary colorectal cancer at the First 
Department of Surgery, Nagasaki University 
Hospital between January 1978 and December 
1986 were examined. There were 59 males and 28 
females, and the mean age was 60.9 years. 
Those who were affected with multiple cancer 
and/or double cancer were excluded. 
Blood-collecting from the Portal Vein 
 A catheter was inserted into the main trunk 
of the drainage veins from the primary tumor, 
and collected the blood sample from the 
marginal vein close to the tumor. To avoid 
the influence of the surgical maneuver, 
blood collecting in 87 patients was done imme-
diately after laparotomy. On the other hand, 
to know the alterations of the portal CEA levels 
caused by the surgical maneuver, portal blood 
sample of 20 patients was also collected at the 
time of resection of the colon and rectum. 
CEA Radioimmunoassay 
  The radioimmunoassay for CEA were per-
formed by the Sandwich method using Dinabot-
RIA Kit, The cut-off level was 2.5 ng/ml. 
Immunohistochemical Staining of CEA 
  Immunohistochemical staining was performed 
using the indirect method of Sternberger.`>> IgG 
fractions from rabbit's anti-CEA and swine 
anti-rabbit IgG and the peroxidase-antiperox-
idase (PAP ) complex were obtained from 
Dakopatts, Copenhagen, Denmark. All incuba-
tion steps of the staining procedure were per-
formed at room temperature. Sections were 
incubated with rabbit's antiserum CEA at the 
primary antibody. Fractions of swine anti-
rabbit IgG were used to link the rabbit horsera-
dish peroxidase anti-peroxidase complex to 
the primary antibody. For the chromogen, 3-3' 
diaminobenzine tetrahydrochloride was used. 
A positive immunoperoxidase reaction consists 
of brown linear staining of the apical surface 
and intraglandular deposits. The specificity 
and accuracy of the immunoreaction was 
checked by negative control using sections 
incubated with rabbit's non-immune serum 
instead of the primary antibody. 
  The procedure of extraction of tissues was 
as previously reported. 10)
Histopathological Study 
 The section for histological study of the tu-
mor was obtained from the neighboring tissue 
to the tumor which was gathered on the mea-
surement of CEA levels and the central part of 
the tumor, and they were fixed in 10% formal-
dehyde and embedded in paraffin and stained 
by hematoxylin and eosin. Dukes' staging clas-
sification was employed as a measure of the 
clinical staging of the colon and rectum. 
Statistics 
  All data were stored on a computer. The tis-
sue CEA levels, CEA staining, portal CEA levels 
and peripheral CEA levels were analyzed and 
the chi-square (X2) test and Student's test was 
performed. 
          RESULTS 
Alteration of Portal CEA Levels during the 
Operation 
 To know the alterations of the portal CEA 
levels caused by the surgical maneuvers, the 
CEA levels of the portal blood collected on 
laparotomy and those on resection of the
Fig. 1. Alterations of the portal CEA levels by 
      the surgical maneuvers. 
Before : portal blood CEA collected immediately 
       after laparotomy. 
After : portal blood CEA collected after surgical 
      operation.
tumor in 20 patients were examined. The mean 
of the CEA levels on laparotomy was 6.20 ± 
5.27 g /ml, and that on resection was 9.35 ± 
7.79 ng/ml, which significantly differed (p< 
0.01). (Fig.1) 
Dukes' Staging and Portal CEA Levels 
 Table 1 shows the relationship between Dukes' 
staging and portal and peripheral CEA levels. 
The positive rate of serial CEA in peripheral 
blood was: Dukes' A; 25 %, Dukes' B: 45 %, 
Dukes' C: 65.1%, Dukes' D: 93.8%. The positive 
rate in the portal blood was Dukes' staging (p 
<0.05). The positive rate in the portal blood 
was also correlated with Dukes' stgaging, and 
was higher than that in peripheral blood on 
any stages. The mean value of serial CEA in 
peripheral blood and in the portal blood on 
Dukes' D stage was significantly higher than 
those on Dukes' A and Dukes' B (p <0.05 ), 
and Dukes' C (p<0.01). 
Cancer Invasion in Colorectal Wall and Portal 
and Peripheral CEA Levels
 Seventy-one patients excluding 16 patients 
with Dukes' D were included for this study 
(Table 2). The mean values of portal and pe-
ripheral CEA showed significant elevation in 
those with infiltration of cancer cells extending 
through the proper muscle layer (pm ). The 
positive rate of portal CEA in those with 
subserosal or serosal invasion was higher than 
that of peripheral CEA. 
Tumor Differentiation and Portal CEA 
 The mean values of portal CEA of moderate-
ly differentiated adenocarcinoma was signifi-
cantly higher than that of well differentiated 
adenocarcinoma (p<0.05). However, there was 
no significant correlation between cell differen-
tiation of adenocarcinoma and peripheral blood 
CEA. Two out of five patients with poorly 
differetiated adenocarcinoma or mutinous car-
cinoma were positive of portal CEA, but the 
mean values of CEA were lower than that of 
moderately differentiated adenocarcinoma 
(Table 3).
       Table 1. Dukes' classification, portal CEA and peripheral CEA 
 Dukes' No. of No.> 2.5 ng/ml(%) Mean values (ng/ml) 
 Stage Patients Portal Peripheral Portal Peripheral 
   A 8 3 (37.5) 2 (25.0) 2.7± 2.2 2.6± 1.9 
   B 20 13 (65.0) 9 (45.0) 6.0± 7.5 4.2± 4.9 
   C 43 35 (81.4) 28 (65.1) 9.9±12.1 8.3±12.1 
   D 16 16 ( 100) 15 (93.8) 45.2±64.7 * 23.0±30.7 W 
 Total 87 67 (77.0) 54 (62.1) 13.9±32.3 8.0±10.2 
*Significant difference between Dukes' A and B (p<0 .05) and C (p<0.01) by the 
 Student's test
       Table 2. Cancer invasion in colonic wall and portal and peripheral CEA 
                                Portal CEA Peripheral CEA
 Depth of cancer No. of 
                            Mean-!-SD Positive Mean±SD Positive    i
nvasion patients (
ng/ml) rate (%) (ng/ml) rate (%) 
      pm 9 3.2± 2.4 33.3 3.1± 2.3 42.9 
       ss 41 10.2±16.3 48.8 8.2±19.2 47.1 
       s 12 33.6±71.1 75.0 8.7± 8.9 68.2 
      si 9 12.2±13.1 77.8 12.3±14.7 57.9 
pm : proper muscle layer ss : subserosal layer s : serosal layer 
 Significant difference in cancer invasion extending through pm (p<0.01) by the Student's 
 test
          Table 3. Tumor differentiation, portal CEA and peripheral CEA 
     Cell No. of No.> 2.5 ng/ml (%) Mean values (ng/ml) 
 difflrentiation Patients Portal Peripheral Portal Peripheral 
 Well 20 9 ( 45) 6 ( 30) 3.9±4.3 2.5±2.3 
 Moderately 41 28 (68.3) 21 (51.2) 9.7±8.1 * 3.4±2.5 
 Poorly 5 2 ( 40) 1 ( 20) 3.2±2.6 2.3±2.9 
 Mutinous 5 2 ( 40) 2 ( 40) 5.8±3.1 4.3±3.6 
 Significant difference between well and moderately differentiated adenocarcinomas 
 (p<0.05), 71 cases excluding 16 cases with Duke's D
Immunohistochemical Staining and Ilisto-
pathology 
  All of 87 colorectal carcinoma were stained 
for CEA. However, each cell type of tumor was 
different in the localization and the intensity 
of CEA in cytoplasm, malignant glands, and 
stroma. CEA was found mainly in the apical 
border of the malignant glands, and positive 
staining was also seen in the luminal secretions, 
in well differentiated adenocarcinoma (Fig. 2a). 
In moderately differentiated adenocarcinomna, 
cytoplasm of neoplastic cells as well as apical 
border were stained for CEA (Fig. 2b ), and 
moreover some portion of stroma beyond bas-
olateral surface were also stained (Fig. 2c ). 
Poorly differentiated adenocarcinoma were 
weakly stained for CEA. A positive stain for 
CEA was mostly seen in the portion with 
gland formation. On the other hand, the 
portion without gland formation did not stain 
at all or just weakly stained in cytoplasm. In 
mucinous carcinoma, CEA was localized in 
free neoplastic cells,but was stained weakly in
mucin or stroma. Apical surface of normal 
colonic epithelial cells adjacent to malignant 
tissue were stained slightly for CEA. Control 
section was not stained. 
Immunohistochemical Grading of CEA Tissue 
Stain 
 To know intensity and localization of CEA in 
tumor reflect tumor CEA levels and plasma 
CEA levels, 87 tumor classified into three 
grades. Grade-l; CEA was localized mainly in 
apical border, but CEA stain in cytoplasm was 
weak and found in under 50 % of the tumor. 
Grade- II ; strong CEA stain was observed not 
only in apical border but also in cytoplasm. 
Over 50% of the tumor were stained. Grade-III ; 
stroma surrounding malignant glands were 
stained as well as the portion of grade II . 
Immunohistochemical Stain and Tumor CEA 
Levels 
 Table 4 shows the relationship between the 
immunohistochemical grading and tumor CEA
                     Fig. 2. Immunohistochemical staining of colon cancer 
Well differentiated adenocarcinoma ; CEA mainly distributes in the apical border of the neoplastic 
cells, Cytoplasm weakly stains for CEA (Fif. 2a X 150). Moderately differentiated adenocarcinoma ; 
apical border and basolateral surface stain, and cytoplasm stains strongly (Fig. 2 b X 250). CEA dis-
tributes diffusely in some parts of stroma of the basolateral surface (Fig. 2cX250).
Table 4. Immunohistochemical grading and tu-
       mor differentiation 
   Grade I II III Total 
 well 1( 6.7) 11(73.3) 3( 20) 15(100) 
 moderately 2( 3.5) 25(43.9) 30(52.6) 57(100) 
 poorly 3( 50) 2(33.3) 1(16.7) 6(100) 
 mutinous 3( 100) 3(100)
Table 5. Immunohistochemical grading and can-
        cerous tissue CEA 
 Grade No. of patients Cancerous tissue (nglg) 
   I 12 3863 
   II 41 5888 
   III 34 10471 ' 
 Significant difference (p<0.05) by the Student's 
 t test
levels. Tumor CEA levels of grade III (p<0.05) 
were singnificantly higher than those of grade 
I and grade II (p<0.1). 
Immunohistochemical Grading and Portal and 
Peripheral CEA Levels 
 CEA levels in peripheral blood tend to be high-
er in grade III, but did not indicate significant 
correlation with any grades. Portal CEA levels 
correlated with grades, and the levels in grade 
III were significantly higher (p<0.01)(Table 5). 
         DISCUSSION 
 In the present study, we found that portal 
CEA levels were higher than peripheral CEA 
levels and elevated after surgical manuever. 
This fact suggests that most of CEA flows from 
tumor tissues into the peripheral blood vessel 
via the portal vein. Portal CEA levels correlat-
ed with Dukes' grading and reflected the pro-
gression of the cancer better than peripheral 
CEA levels. Portal CEA levels were especially 
high in the case of tumors with invasion over 
the intestinal walls, and correlated with the 
differentiation of tumor. 
 Several factors contributing to elevated pe-
ripheral CEA levels have been pointed out: 1) 
CEA paroductivity of tumor 2) release of CEA
from tumor into the blood stream 7'11) 3) clear-
ance of circulating CEA12) 4) reabsorption of 
CEA excreted in the intestine. 1 3 ) Among these 
factors, CEA productivity is the most essential. 
  There are many immunohistochemical studies 
which attempted to evaluate elevated plasma 
CEA levels based on the intensity of stain for 
CEA or the localization of CEA. However, it 
is difficult to grade tumor tissue by immuno-
histochemical staining because of hetrogenous 
staining patterns, which represent the interrela-
tion of several clones of tumor. Previous re-
searches which attempted to evaluate tumor 
CEA levels could be divided into those focused 
on the intensity of stain for CEA3) and those 
focused on the localization of CEA.2''1'5 
Hamada et al. classified into three grades of 
apical, cytoplasmic and stromal based on the 
localization of CEA in tumor. ) In our study, 
as in the Wiggers and his colleagues' study, 5 
we could not strictly differentiate between the 
apical type from the cytoplasmic type. Conse-
quently we categorized grades based on both 
the localization and the stain, and observed 
a high correlation between grades and tumor 
CEA levels, the higher the grade the higher the 
CEA levels. This suggests that the immunohisto-
chemical stain for CEA may be as a quantita-
tive indicator as well as qualitative.
    Table 6. Immunohistochemical grading and portal and peripheral CEA 
 Grade No. of No.>2.5 ng/ml (%) Mean CEA values (ng/ml)    ra e 
          Patients Portal Peripheral Portal Peripheral 
   I 7 3(42.9) 3 (42.9) 4.7±3.9 4.4±3.2 
   II 34 24 (70.5) 18 (52.9) 5.7±4.5 4.6±5.6 
   III 30 25 (83.3) 18 (60.0) 8.0±8.9 * 6.5±9.5 
 Significant difference between grade II and III (p<0.05) by the Student's t test
 The study which investitgated the relation-
ship between tumor CEA levels evaluated per 
unit weight and peripheral CEA levels reported 
no significant correlation between them,6) we 
did not observe any correlation between the 
amount of CEA per unit weight of tumor tissue 
and peripheral CEA levels either.10) 
 Many studies which investigated the localiza-
tion of CEA in tumor and the staining immuno-
histochemically in relation to peripheral CEA 
reported no correlation.2,3) In our study, we ob-
served a significant increase of portal CEA 
levels in grade III, though we did not observe 
correlation between grading and peripheral CEA 
levels. 
 In terms of tumor differentiation, moderately 
differentiated adenocarcinoma showed signifi-
cantly higher portal CEA levels than well 
differentiated ones. This is assumed to reflect 
the phenomenon that moderately differentiated 
adenocarcinoma contains a large amout of CEA 
and has wide distribution of CEA shown by 
immunohistochemical staining. On the other 
hand, well differentiated adenocarcinoma re-
vealed low portal CEA levels, though it contain-
ed a large amount of CEA. This can be explain-
ed by that most of the CEA in the tumor was 
excreted into the lumen of the intestine and 
only a little was released into the portal vein, 
because well differentiated adenocarcinoma was 
found to maintain polarity of the cell surface 
and the structure of normal colonic mucosal 
cells,1`1,15) and because luminal excretions were 
stained for CEA by immunohistochemical stain-
ing. Poorly differentiated adenocarcinoma and 
mucinous carcinoma had weak stain for CEA 
and low portal CEA levels and those findings 
were compatible with the studies of Ahnen et 
al.,14) and Goslin et al.16) 
 In conclusion, portal CEA levels correlated 
well with tumor CEA content, invasion of tu-
mor, and immunohistochemical grading for 
CEA, but not with peripheral CEA levels. This 
difference might be caused mainly by the metab-
olism in the liver, since CEA flows from the 
portal vein into the systemic circulation through 
the liver. Shuster et al. carried out an experi-
ment in which they injected labeled CEA gath-
ered specifically in the liver and was degraded 
and excreted within one hour, with a half life
of a day long.12) Generally CEA in neoplastic 
tissue is excreted into the lumen of the intes-
tine. 2,1.1) As tumor grows, we suppose, basal 
membrane of the epithelium and the vascular 
system in stroma are lesioned, which causes 
inhibition of CEA excretion and the transfer 
of CEA into the portal vein. The findings of 
this study suggest that the mechanism of CEA 
transfer from tumor into the portal vein is the 
most important factor to evaluate the CEA 
values in peripheral blood vessels. 
          REFERENCES
1) GOLD, P. and FREEDMAN, S. 0. : Specific car-
   cinombryonic antigens of the human digest-
   ive systems. J. Exp. Med., 122 : 457-481, 1965. 
2) Pil-IL, E., MCN<LNGTAN, J. Ma, J., et al., : Im-
   munohistological patterns of carcinoembry-
   onic antigen in colorectal carcinoma. Corre-
   lation with staging and blood levels. Patho-
   logy, 12 : 7-13, 1980. 
3) MIDIR[, G., ANANTI, C., BENEDE'rFI, M., et al., 
   CEA tissue staining in colorectal cancer 
   patients. A way to improve the usefullness of 
   serial serum CEA evaluation. Cancer, 55 : 26 
   24-2629, 1985. 
4) HAMADA, Y., YAMA,MURA, M., Hlol.[, K., et al., 
   Immunohistochemical study of carcinoem-
   bryonic antigen in patients with colorectal 
   cancer. Correlation with plasma carcinoem-
   bryonic antigen levels. Cancer, 55 : 136-141, 
  1985. 
5) WIGGeRS, T., RENDS, J. W., VERSTI.INEN, C., et 
   al., : Prognostic significance of CEA immno-
   reactivity patterns in large bowel carcinoma 
   tissue. Br. J. Cancer. 54 : 409-414, 1986. 
6) M[RT[N, F. and MIRTnv, M. S. : Radioimmuno-
   assay of carcinoembryonic antigen in 
   extracts of human colon and stomach. Int. J. 
   Cancer, 9 : 641-647, 1972. 
7) WAGENTER, C., MULLER WALLRAF, R., NISSON, S., 
   et al., : Localization and concentration of 
   carcinoembryonic antigen (CEA) in gastro-
   intestinal tumors correlation with CEA 
   levels in plasma. J. Natl. Cancer Inst., 62 : 5 
  39-541, 1981. 
8) TABUCI-I[, Y., DEGUCI-II, H., IMANISI-II, K., et al. 
   Carcinoembryonic antigen (CEA) levels of 
   peripheral and portal blood and tumor histo-
   pathology in colorectal cancers. J. Jpn. Surg. 
   Soc., 87 : 1540-1547, 1986. 
9) STERNBERGER, L. A., HARDY, P. H., CucuL[s, J.
   J., et al., : The unlabeled antibody enzyme 
   method of immunohistochemistry : Prepara-
   tion and properties of soluble antigen-
   antibody complex (horseradish peroxidase 
   antihorseradish peroxidase) and its use in 
   identification of spirochetes. J. Histochem. 
   Cytochem., 18 : 315-333, 1970. 
10) SIIMOYAMA, T., FUKUDA, Y., ITOI-I, S., et al., 
   Clinical evaluation of carcinoembryonic anti-
   gen (CEA) in colorectal cancer. Acta Medica 
   Nagasaki., 31 : 294-302, 1986. 
11) BIVINS, B. A., MEEKER, W. R. and GRIGGE\, W. 
   0. : Carcinoembryonic antigen (CEA) levels 
   and tumour histology in colon cancer. J. 
   Surg. Res., 18 :257-261, 1975. 
12) Srius oR, J., SILVE:RMAN, M. and GOLD, P. 
   Metabolism of human carcinoembryonic
   antigen in xenogeneic animals. Cancer, Res.,
   33 :65-68, 1973. 
13) RSSTLTBI3s, DMNNADKAILNI and HAMONSEY : Faecal 
   carcinoembryonic antigen colorectal cancer 
   patients. Gut, 27 : 901-905, 1986. 
14) AIL`'EN, D. J., NAKANE, P. K. and BROWN, W. 
   R. : Ultrastructural localization of carcino-
   embryonic antigen in normal intestine and 
   colon cancer. Cancer, 49 : 2077-2090, 1982. 
15) HuTrinc, E., LAUMONJER, R., BUR•rIN, P., et al., 
   An optimal and ultrastructural study of the 
   localization of carcinoembryonic antigen
   (CEA ) in normal and cancerous human 
   rectocolonic mucosa. Laboratory Investiga-
   tion, 34 :97-107, 1976. 
16) G0sLI\', R., O'URIEN, M. J., SrI I;i.I:, G., et al., 
   Correlation of plasma CEA and CEA tissue 
   staining in poorly differentiated colorectal 
   cancer. Am. J. Medicine, 71 :246-250', 1981.
